Related Experiment Videos

Iron deposition in cranial bone marrow with sickle cell disease: MR assessment using a fat suppression technique

K Kaneko1, J H Humbert, M S Kogutt

  • 1Department of Radiology, Tulane University Medical Center, New Orleans, LA 70112-2699.

Pediatric Radiology
|January 1, 1993
PubMed

Insights

Magnetic resonance imaging (MRI) helps distinguish bone marrow changes in sickle cell disease (SCD) patients. T2-weighted MRI effectively identifies iron deposition from transfusions, differentiating it from marrow hyperplasia.

Area of Science:

  • Radiology
  • Hematology
  • Medical Imaging

Background:

  • Sickle cell disease (SCD) often requires transfusion therapy.
  • Transfusions can lead to iron overload in bone marrow.
  • Differentiating iron deposition from marrow hyperplasia is crucial for patient management.

Purpose of the Study:

  • To discriminate bone marrow changes in SCD patients due to iron deposition versus hematologic marrow hyperplasia.
  • To evaluate the utility of different MRI sequences for this discrimination.

Main Methods:

  • Thirteen SCD patients on transfusion therapy and 8 controls underwent MRI.
  • T1-weighted spin echo and T2-weighted fast spin echo with fat suppression sequences were used.
  • Bone marrow signal intensity was analyzed to assess iron deposition and hyperplasia.

Main Results:

  • T1-weighted images showed minimal evidence of iron deposition.
  • T2-weighted fast spin echo images revealed significantly lower cranial bone marrow signal in SCD patients compared to controls.
  • This decreased signal in SCD patients was attributed to iron deposition.

Conclusions:

  • T2-weighted fast spin echo MRI with fat suppression is effective in detecting bone marrow iron deposition in SCD patients.
  • Iron deposition due to transfusion therapy is the primary cause of decreased marrow signal, not hyperplasia.
  • MRI findings aid in managing iron overload in transfusion-dependent SCD patients.

Related Concept Videos